ZHEJIANG ORIENT GENE BIOTECH CO.,LTD. — TTAB Proceedings
ZHEJIANG ORIENT GENE BIOTECH CO.,LTD. is a party to 2 TTAB proceedings.
Proceedings
- Proceeding 97178435 — Extensions of Time to Oppose, Terminated (filed 2022-06-23) against Roche Diabetes Care, Inc. as defendant
- Proceeding 97178457 — Extensions of Time to Oppose, Terminated (filed 2022-06-23) against Roche Diabetes Care GMBH as defendant
Marks in These TTAB Matters
Recent Live Filings
- ACCUFLUOR — Registered, filed 2023-12-13
- URCHECK — Registered, filed 2023-09-27
- ACCUBIO — Registered, filed 2022-11-20
- ZOG — Registered, filed 2022-05-10
- ZOG — Registered, filed 2022-05-06
- ZOG — Registered, filed 2022-05-06
- ZOG — Registered, filed 2022-05-06
- ZOG — Registered, filed 2022-05-06
- ACCUBIO — Registered, filed 2021-12-17
- ACCUBIO — Registered, filed 2021-12-17
- ACCUBIO — Registered, filed 2021-12-17
- ORIENT GENE — Registered, filed 2021-07-12
- ORIENT GENE — Registered, filed 2021-07-12
- ORIENT GENE — Registered, filed 2021-07-12
- ORIENT GENE — Registered, filed 2019-05-31
Common TTAB Counterparties
- Roche Diabetes Care GMBH — 1 proceedings
- Roche Diabetes Care, Inc. — 1 proceedings
Recent TTAB Timeline
- 2022-08-10: 97178435 — RELINQUISHMENT ACKNOWLEDGED; APPLICATION RELEASED TO TRADEMARKS involving Roche Diabetes Care, Inc.
- 2022-08-10: 97178457 — RELINQUISHMENT ACKNOWLEDGED; APPLICATION RELEASED TO TRADEMARKS involving Roche Diabetes Care GMBH
- 2022-08-10: 97178457 — RELINQUISHMENT ACKNOWLEDGED involving Roche Diabetes Care GMBH
- 2022-08-10: 97178435 — RELINQUISHMENT ACKNOWLEDGED involving Roche Diabetes Care, Inc.
- 2022-08-09: 97178457 — P RELINQUISHMENT OF EXT involving Roche Diabetes Care GMBH
- 2022-08-09: 97178435 — P RELINQUISHMENT OF EXT involving Roche Diabetes Care, Inc.
- 2022-08-09: 97178457 — P RELINQUISHMENT OF EXT involving Roche Diabetes Care GMBH
- 2022-08-09: 97178435 — P RELINQUISHMENT OF EXT involving Roche Diabetes Care, Inc.
- 2022-07-19: 97178457 — EXTENSION OF TIME GRANTED involving Roche Diabetes Care GMBH
- 2022-07-19: 97178435 — EXTENSION OF TIME GRANTED involving Roche Diabetes Care, Inc.
- 2022-07-19: 97178457 — ADD'L 60-DAY REQUEST TO EXT TIME TO OPPOSE involving Roche Diabetes Care GMBH
- 2022-07-19: 97178435 — ADD'L 60-DAY REQUEST TO EXT TIME TO OPPOSE involving Roche Diabetes Care, Inc.
- 2022-07-19: 97178435 — EXTENSION OF TIME GRANTED involving Roche Diabetes Care, Inc.
- 2022-07-19: 97178457 — EXTENSION OF TIME GRANTED involving Roche Diabetes Care GMBH
- 2022-07-19: 97178435 — ADD'L 60-DAY REQUEST TO EXT TIME TO OPPOSE involving Roche Diabetes Care, Inc.
- 2022-07-19: 97178457 — ADD'L 60-DAY REQUEST TO EXT TIME TO OPPOSE involving Roche Diabetes Care GMBH
- 2022-06-23: 97178435 — EXTENSION OF TIME GRANTED involving Roche Diabetes Care, Inc.
- 2022-06-23: 97178457 — EXTENSION OF TIME GRANTED involving Roche Diabetes Care GMBH
- 2022-06-23: 97178457 — FIRST 30-DAY REQUEST TO EXT TIME TO OPPOSE involving Roche Diabetes Care GMBH
- 2022-06-23: 97178435 — FIRST 30-DAY REQUEST TO EXT TIME TO OPPOSE involving Roche Diabetes Care, Inc.
- 2022-06-23: 97178457 — EXTENSION OF TIME GRANTED involving Roche Diabetes Care GMBH
- 2022-06-23: 97178435 — EXTENSION OF TIME GRANTED involving Roche Diabetes Care, Inc.
- 2022-06-23: 97178457 — FIRST 30-DAY REQUEST TO EXT TIME TO OPPOSE involving Roche Diabetes Care GMBH
- 2022-06-23: 97178435 — FIRST 30-DAY REQUEST TO EXT TIME TO OPPOSE involving Roche Diabetes Care, Inc.